Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 2.29 -4.18%
ERNA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.90M
- EPS (TTM)
- -$13.63
- Dividend yield
- None
- 52-week range
- 2.15 – 71.50
- Day range
- 2.15 – 2.39
- Volume / Avg
- 210.54K / 472.01K
- Beta
- —
- Shares outstanding
- 1.63M
- Next earnings
- Nov 6, 2026
52-week range
ERNA stock today
Shares of Ernexa Therapeutics (ERNA) finished higher on Oct 7 at $2.39, a gain of 6.94% or $0.155 per share, versus the S&P 500's 0.22% decline. Trading was light, with 210.54K shares changing hands, about 45% of the average daily volume. At this level, ERNA sits near the bottom of its 52-week range of $2.15 to $71.50: 96.7% below the high and 11.2% above the low.
Ernexa Therapeutics has posted a net loss over the last twelve months (EPS of -$13.63), so its P/E ratio is not meaningful. Ernexa Therapeutics's next earnings report is expected on Nov 6, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Ernexa Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
Earnings
Earnings history- Next report
- Nov 6, 2026
- EPS estimate
- $-3.84
Ernexa Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SXTP60 Degrees Pharmaceuticals Inc. | 1.10 | -0.90% | $3.87M | vs ERNA |
| PCSAProcessa Pharmaceuticals Inc. | 1.42 | -5.96% | $3.97M | vs ERNA |
| GRIGRI Bio Inc. | 1.85 | -2.63% | $4.04M | vs ERNA |
| JUNSJupiter Neurosciences Inc. | 2.84 | -0.70% | $3.74M | vs ERNA |
| SXTCChina SXT Pharmaceuticals Inc. Class A | 2.83 | +126.40% | $3.74M | vs ERNA |
| EOCNEocene Ltd. | 3.46 | +2.91% | $3.69M | vs ERNA |
| RDHLRedhill Biopharma Ltd. ADR | 0.474 | -2.07% | $4.21M | vs ERNA |
| HCWBHCW Biologics Inc. | 1.56 | -0.64% | $3.49M | vs ERNA |
Indexes, lists and sector
Ernexa Therapeutics stock FAQ
What is Ernexa Therapeutics's stock price today?
ERNA last traded at $2.39 as of Oct 7, 4:00 PM EDT, up 6.94% on the day. Prices are delayed at least 15 minutes.
When is Ernexa Therapeutics's next earnings date?
Ernexa Therapeutics is expected to report earnings on Friday, November 6, 2026. Analysts expect EPS of $-3.84.
What is the ERNA 52-week high?
The 52-week high for ERNA is $71.50 and the 52-week low is $2.15. The stock is currently 96.7% below its high.